Clinical Trial Update: Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating individual responses to hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis arising from…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Cancer
• Atypical Mesothelial Proliferation
• Colorectal Cancer
• Ovarian Cancer
• Peritoneal Carcinomatosis
• Peritoneal Mesothelioma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Peritoneal Mesothelioma, Peritoneal Carcinomatosis | Phase 1 | Status: RECRUITING